PATENT CLAIM ANALYSIS

Application Number: 16251617
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["424", "001110"]

Abstract:
Methods of treating cancer by administering a compound of Formula I, or a pharmaceutically acceptable salt or solvate thereof, in combination with other cancer treatments are described, wherein R 1  is halo; R 2  is halo; and Q is CH or N.

Claim (Index 6):
The method according to according to any one of  claims 1  and  3 - 5 , wherein the one or more additional treatment(s) are selected from (1) surgery, (2) one or more additional chemotherapeutic agent(s), (3) one or more hormone therapy(s), (4) one or more antibody(s), (5) one or more immunotherapy(ies), (6) radioactive iodine therapy, and (7) radiation.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 99.0
- Lexical Diversity: 1.33333
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13145054', '14340871', '13249815', '11753514', '12393806']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8079095455500575
- 35 USC 102 Novelty (BERT): 0.5101021795331097
- Combined Prediction Score: 0.7781288089483627
- Mean Citation Score: 338.013512
- Max Citation Score: 351.83926
- Similarity Product: 204.03314800771

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test